U.S. markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
34.39+0.19 (+0.56%)
At close: 4:02PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close34.20
Bid34.47 x 1200
Ask34.43 x 3200
Day's Range33.96 - 34.55
52 Week Range26.45 - 43.08
Avg. Volume39,909,840
Market Cap191.815B
Beta (5Y Monthly)0.62
PE Ratio (TTM)20.15
EPS (TTM)1.71
Earnings DateApr 26, 2021 - Apr 30, 2021
Forward Dividend & Yield1.56 (4.54%)
Ex-Dividend DateJan 28, 2021
1y Target Est41.09
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-21% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Reuters

    NHS England invites people aged 56 to 59 to book COVID-19 vaccinations in coming week

    NHS England has invited people aged 56 to 59 to book COVID-19 vaccinations in the coming week, with letters to 850,000 people in that age bracket landing on doorsteps from Saturday and another 850,000 due to land Monday. "The latest invites have been sent after more than eight in 10 people aged 65 to 69 took up the offer of a jab", the National Health Service said in an emailed statement on Sunday. "NHS staff have vaccinated more than 18 million people across England, meaning more than one third of the adult population have already received the life-saving jab."

  • Reuters

    Chile donates 20,000 doses of Sinovac coronavirus vaccine to Ecuador

    Ecuador has received a donation of some 20,000 doses of the Sinovac coronavirus vaccine from Chile, Ecuador's President Lenin Moreno said on Saturday, in a sign of the stark disparities in South American countries' inoculation campaigns. Chile, one of Latin America's wealthiest countries, ranks sixth in the world for per-capita vaccine shots administered, according to Reuters data, with a quarter of the population now having received a dose.

  • Motley Fool

    How Worried Should Investors Be About the South African Coronavirus Variant?

    The B1351 coronavirus variant from South Africa poses a threat to the currently authorized vaccines from Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX)/Pfizer (NYSE: PFE) because they weren't specifically designed to protect against that variant. In this video from Motley Fool Live, recorded on Feb. 22, Fool.com contributors Brian Orelli and Keith Speights discuss the ins and outs of the vaccines' potential to protect against the variants and what the companies are doing to deal with the new challenge. Brian Orelli: We got some data last week published in the New England Journal of Medicine on the coronavirus vaccines protecting against the South African variant -- that's the B1351 -- by Pfizer and BioNTech vaccine, the neutralization was weaker by about two-thirds.